Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Varian Medical Systems and Brainlab Offer Advanced Radiosurgical Capabilities

By HospiMedica International staff writers
Posted on 19 Jul 2010
Varian Medical Systems (Varian, Palo Alto, CA, USA) and Brainlab (Feldkirchen, Germany) have announced the expansion of their partnership to incorporate Novalis technology elements with their TrueBeam STx system.

The expanded suite of products, named "Novalis Powered by TrueBeam STx,” is a natural extension of a relationship between the two companies that began in 1996, and grew with their collaboration around the Novalis Tx radiosurgery platform, which was launched in 2007. More...
Novalis Powered by TrueBeam STx will give clinicians radiosurgical and image-guidance capabilities designed for targeted stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments. It will also include Brainlab iPlan treatment planning and ExacTrac room-based X-ray imaging technology, as well as Varian's HD120 MLC multileaf collimator for high resolution beam shaping.

"TrueBeam STx technology will significantly enhance the Varian-Brainlab offering to the radiosurgery market with its significant speed and precision,” said Dow Wilson, president of oncology systems at Varian. "The Novalis Radiosurgery Program includes a comprehensive package of clinical applications, workflow, knowledge base, and training for radiosurgery,”

"Expanding our partnership with Varian to combine TrueBeam STx with the Novalis Radiosurgery Program gives us a stronger and broader platform for innovation in neurosurgery,” said Stefan Vilsmeier, CEO of Brainlab. "We believe the combination of our leading technologies can help make significant clinical advancements in the fight against cancer and other neurological conditions. Our goal is to increase access to advanced treatment.”

The TrueBeam STx system is specially configured for advanced radiosurgery and is designed to deliver treatments up to 50% faster, with a dose delivery rate of up to 2,400 monitor units per minute, double the maximum output of earlier Varian systems. This makes it possible to offer greater patient comfort by shortening treatments, and to improve precision by leaving less time for tumor motion during dose delivery.

Related Links:

Varian Medical Systems
Brainlab




Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
OR Table Accessory
Angular Accessory Rail
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.